Medasense was independently chosen by the “MedTech Strategist” magazine, to be one of the “Start-Ups To Watch” in the most recent issue. The “MedTech Strategist” is a medical device magazine providing objective insight into the most important topics and trends in the industry.
Click here for the full article.
Medasense Biometrics to present at the 2015 Annual Meeting of the American Society of Anesthesiologists (ASA): “Ability of the Nociception Level to Detect Noxious Stimuli During Propofol-Remifentanil Anesthesia” (Monday October 26th, 15:15-17:15, Hall B2-Area B, Monitor 05, A3141)